Risk factors for allograft failure in United Kingdom renal transplant recipients treated with cyclosporine A

Transplantation

Volumn 79, Issue 8, 2005, Pages 953-957

  He, Xiang ^a,b   Johnston, Atholl ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Clinical Pharmacology   (United Kingdom)

Author keywords

Allograft failure; Cyclosporine A; Renal transplantation; Risk factors; Stratified Cox model

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CREATININE BLOOD LEVEL; DEATH; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HALF LIFE TIME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; TREATMENT OUTCOME; UNITED KINGDOM;

CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 17844410122     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000156159.72708.DE     Document Type: Article

References (34)

1. Opelz G. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study. Kidney Int Suppl 1995; 52: S89-S92.
2. Hariharan S. Long-term kidney transplant survival. Am J Kidney Dis 2001; 38: S44-S50.
3. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
4. Gjertson DW, Cecka JM. Living unrelated donor kidney transplantation. Kidney Int 2000; 58: 491-499.
5. Gill JS, Abichandani R, Khan S, et al. Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 2002; 61: 2193-2200.
6. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318.
7. Sam R, Leehey DJ. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 1837-1838.
8. Prommool S, Jhangri GS, Cockfield SM, et al. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11: 565-573.
9. Cho YW, Terasaki PI. Long-term survival. Clin Transpl 1988: 277-282.
10. Kasiske BL, Snyder J. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002; 13: 1067-1072.
11. Meier-Kriesche HU, Cibrik DM, Ojo AO, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 2002; 50: 14-17.
12. Wissing KM, Abramowicz D, Broeders N, et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation 2000; 70: 464-472.
13. Joosten SA, van Kooten C, Paul LC. Pathogenesis of chronic allograft rejection. Transpl Int 2003; 16: 137-145.
14. Joseph JT, Kingsmore DB, Junor BJ, et al. The impact of late acute rejection after cadaveric kidney transplantation. Clin Transplant 2001; 15: 221-227.
15. Sijpkens YW, Doxiadis II, Mallat MJ, et al. Early versus late acute rejection episodes in renal transplantation. Transplantation 2003; 75: 204-208.
16. First MR. Renal function as a predictor of long-term graft survival in renal transplant patients. Nephrol Dial Transplant 2003; 18 Suppl 1: i3-i6.
17. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295.
18. Kasiske BL, Andany MA, Hernandez D, et al. Comparing methods for monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis 2001; 38: 1065-1073.
19. Toma H, Tanabe K, Tokumoto T, et al. Time-dependent risk factors influencing the long-term outcome in living renal allografts: donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation. Transplantation 2001; 72: 940-947.
20. Matas AJ, Gillingham KJ, Humar A, et al. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54-58.
21. El Agroudy AE, Bakr MA, Hassan NA, et al. Characteristics of long-term live-donor renal allograft survivors. Am J Nephrol 2003; 23: 165-171.
22. Mandal AK, Snyder JJ, Gilbertson DT, et al. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation 2003; 75: 494-500.
23. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73: 70-74.
24. Roodnat JI, Mulder PG, van Riemsdijk IC, et al. Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation 2003; 75: 799-804.
25. Nampoory MR, Johny KV, Costandi JN, et al. Inferior long-term outcome of renal transplantation in patients with diabetes mellitus. Med Princ Pract 2002; 11: 29-34.
26. Norio K, Makisalo H, Isoniemi H, et al. Are diabetic patients in danger at renal transplantation? An invasive perioperative study. Eur J Anaesthesiol 2000; 17: 729-736.
27. Gill JS, Abichandani R, Kausz AT, et al. Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int 2002; 62: 1875-1883.
28. Ponticelli C, Villa M, Cesana B, et al. Risk factors for late kidney allograft failure. Kidney Int 2002; 62: 1848-1854.
29. Lee WC, Shu KH, Cheng CH, et al. Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol 2001; 21: 300-306.
30. Einollahi B, Hajarizadeh B, Bakhtiari S, et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 2003; 18: 836-840.
31. Bechstein WO, Dette K, Golling M, et al. [Development of primary malignancies after liver and kidney transplantation and the treatment approach]. Kongressbd Dtsch Ges Chir Kongr 2002; 119: 398-404.
32. Werner W, Wilhelm S, Poschel K, et al. [Follow-up in kidney transplantation. Which complications are likely?]. MMW Fortschr Med 2003; 145: 36-39.
33. Jorga A, Holt DW, Johnston A. Therapeutic drug monitoring of cyclosporine. Transplant Proc 2004; 36: 396S-403S.
34. Jorga A, Johnston A, Holt DW. Patient management by cyclosporine C2 monitoring. Transplantation 2004; 77: 323-324.